Delivery Order SPE2DB22D3301-SPE2DB25FX3MY
Award Date
10/10/24
Potential Completion Date
10/11/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,493.05, is for the delivery of LUMASON 25 MG VIALS. The award is not set aside and allows AmerisourceBergen to provide a range of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,493.05 firm fixed-price contract is for the supply of 4,568,190 units of the drug Lumason 25 mg vials. The delivery order is not set aside and has an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,150,418 units of the drug LUMASON 25 MG VIALS. The $1,496.50 firm fixed price contract has an ultimate completion date of October 21, 2024. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,086.97 firm fixed-price contract is for the supply of 4,565,309,964 units of the medical product Lumason 25 mg vials. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for delivering a comprehensive range of medical commodities...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lumason 25 mg vials, a pharmaceutical product. The contract has a ceiling value of $1,190.24 and a period of performance through March 13, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp is the prime...
This federal contract award, valued at $1,792.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lumason 25 mg vials, a medical product used in healthcare settings. The contract has an ultimate completion date of January 29, 2025 and is structured as a Firm Fixed Price delivery order. This award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award is for pharmaceutical products, specifically LUMASON 25 MG VIALS, to the Defense Logistics Agency (DLA) by prime contractor AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract has a ceiling value of $5,810.00 and is a Delivery Order with a Firm Fixed Price pricing type. The award date is August 7, 2023 and the ultimate completion date is August 8, 2023. The contract is not set aside. AmerisourceBergen Drug Corp holds a larger...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution services company. The order is for OPTISON VIAL 3ML, a pharmaceutical product, with a potential value of $2,149.36 and a completion date of March 27, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA to provide a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,527.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of OMNIPAQUE 300 MG/ML VIAL 10ML, a medical product, with a completion date of February 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,500.56, is for the delivery of OPTISON VIAL 3ML medical products. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...